It will oversee all laboratory operations and processes and will have responsibility for clinical governance, quality assurance, staff training, sample processing and information management, investors were told.
SourceBio said it will run the service on behalf of outsourcing specialist Mitie for the remainder of this early phase, adding that it is “working towards involvement in a potential UK-wide programme”.
Chairman Jay LeCoque said: “We are very proud to support the UK’s national testing effort to bring gold-standard testing to the local communities as part of the effort to get the nation back to work.
“The need for localised testing and monitoring of infections is critical as the vaccine programme accelerates. This project also highlights our continued work with the DHSC on multiple fronts as they work to manage the pandemic as it evolves.”
Four mobile testing labs using Oxford Nanopore’s LamPORE tests for coronavirus have been deployed in the pilot.
Larger units can process more than 1,500 samples a day, with 1,000 tests a day targeted for smaller vehicles.
SourceBio is already working closely with the Department of Health and Social Care, providing COVID-19 antigen RT-PCR testing services.
It has processed approaching 1mln tests for the DHSC and the NHS, private hospital groups and commercial customers since first offering its service in May last year.